Search
Menu
Home
HTB
2017
November
24
24 November 2017
Contents
Antiretrovirals
Coformulated dolutegravir plus rilpivirine approved in US (Juluca)
Darunavir-based single pill FDC approved in EU (Symtuza)
HTB RSS
Early access
IAS 2025: We will not be erased – a community Call to Action
15 July 2025
13th IAS Conference on HIV Science (IAS 2025): Introduction and early reports
13 July 2025
HIV cure research at IAS 2025
12 July 2025
Global Fund plans for lenacapavir PrEP in selected countries
9 July 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
AIDS quilts at the Tate: reflection and also anger
8 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate
